LIQUID INJECTABLE FORMULATION OF DISODIUM PAMIDRONATE

Details for Australian Patent Application No. 2002220393 (hide)

Owner PHARMACEUTICAL PARTNERS OF CANADA INC.

Inventors SZYMANSKI, Dennis; HAHN, Sam

Pub. Number AU-A-2002220393

PCT Pub. Number WO2002/089768

Priority 2,347,330 10.05.01 CA

Filing date 15 November 2001

Wipo publication date 18 November 2002

International Classifications

A61K 009/08 Medicinal preparations characterised by special physical form - Solutions

A61K 031/663

A61P 019/08 Drugs for skeletal disorders

A61P 019/10 Drugs for skeletal disorders

A61P 035/04 Antineoplastic agents

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002220393

26 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002220394-Method and apparatus for determining in situ the acoustic seal provided by an in-ear device

2002220392-Mammalian sex selection using genetic modification